rasburicase 1.5 MG Injection
- RxCUI
- 1790344
- RxNorm name
- rasburicase 1.5 MG Injection
- Display name
- rasburicase 1.5 MG Injection
- Full name
- rasburicase 1.5 MG Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103946 | Elitek | rasburicase | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Elitek | RASBURICASE | Sanofi-Aventis U.S. LLC | 0ae10bc4-6b65-402f-9db5-2d7753054922 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 1790344 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0ae10bc4-6b65-402f-9db5-2d7753054922 | rasburicase 1.5 MG Injection | SCD | 23 | These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek ® . ELITEK (rasburicase) for injection, for intravenous use Initial U.S. Approval: 2002 | 20250508 |
| 0ae10bc4-6b65-402f-9db5-2d7753054922 | rasburicase 1.5 MG Injection | PSN | 23 | These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek ® . ELITEK (rasburicase) for injection, for intravenous use Initial U.S. Approval: 2002 | 20250508 |